General Committee Authority. Each Committee has solely the powers expressly assigned to it in this Section 2. No Committee will have any power to amend, modify, or waive compliance with this Agreement. It is expressly understood and agreed that the control of decision-making authority by Surface or Novartis, as applicable, pursuant to Section 2.6, so as to resolve a disagreement or deadlock on a Committee for any matter will not authorize either Party to perform any function or exercise any decision-making right not delegated to a Committee or such Party, and that neither Surface nor Novartis has any right to unilaterally modify, amend or waive its own compliance with, the terms of this Agreement.
Appears in 4 contracts
Samples: Collaboration Agreement (Coherus BioSciences, Inc.), Collaboration Agreement (Surface Oncology, Inc.), Collaboration Agreement (Surface Oncology, Inc.)
General Committee Authority. Each Committee has solely the powers expressly assigned to it in this Section 2Article 4 and elsewhere in this Agreement. No Committee will have any power to amend, modify, or waive compliance with this Agreement. It is expressly understood and agreed that the control of decision-making authority by Surface Unum or NovartisSGI, as applicable, pursuant to Section 2.64.6, so as to resolve a disagreement or deadlock on a Committee for any matter will not authorize either Party to perform any function or exercise any decision-making right not delegated to a Committee or such Party, and that neither Surface Unum nor Novartis SGI has any right to unilaterally modifymodify or amend, amend or waive its own compliance with, the terms of this Agreement.
Appears in 2 contracts
Samples: Collaboration Agreement (Unum Therapeutics, Inc.), Collaboration Agreement (Unum Therapeutics, Inc.)
General Committee Authority. Each Committee has solely the powers expressly assigned to it in this Section 2. No Committee will have any power to amend, modify, or waive compliance with this Agreement. It is expressly understood and agreed that the control of decision-making authority by Surface Xencor or Novartis, as applicable, pursuant to Section 2.62.5, so as to resolve a disagreement or deadlock on a Committee for any matter will not authorize either Party to perform any function or exercise any decision-making right not delegated to a Committee or such Party, and that neither Surface Xencor nor Novartis has any right to unilaterally modify, amend or waive its own compliance with, the terms of this Agreement.. -41-
Appears in 1 contract
General Committee Authority. Each Committee has shall have solely the powers expressly assigned to it in this Section 2Article 2 and elsewhere in this Agreement. No Committee will shall have any power to amend, modify, or waive compliance with this Agreement. It is expressly understood and agreed that the control of decision-making authority by Surface Medivation or NovartisPartner, as applicable, pursuant to Section 2.62.7, so as to resolve a disagreement or deadlock on a Committee for any matter will not authorize either Party to perform any function or exercise any decision-making right not delegated to a Committee or such PartyCommittee, and that neither Surface Medivation nor Novartis has Partner shall have any right to unilaterally modifymodify or amend, amend or waive its own compliance with, the terms of this Agreement.
Appears in 1 contract